The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Tems...

Por Busaidy, Naifa L., LoRusso, Patricia, Lawhorn, Kristie, Hess, Kenneth R., Habra, Mohammed Amir, Fu, Siqing, Hong, David S., Chen, Helen X., Doyle, Lawrence A., Kurzrock, Razelle, Naing, Aung
Publicado no Oncologist (2015)

Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: A phase I trial of bortezomib plus bevacizumab

Por Falchook, Gerald S, Wheler, Jennifer J, Naing, Aung, Jackson, Edward F, Janku, Filip, Hong, David, Ng, Chaan S, Tannir, Nizar M, Lawhorn, Kristie N, Huang, Mei, Angelo, Laura S, Vishwamitra, Deeksha, Hess, Kenneth, Howard, Adrienne N, Parkhurst, Kristin L, Amin, Hesham M, Kurzrock, Razelle
Publicado no Oncotarget (2014)